Sign in

CIK 0001729427

  • Non-accelerated filer
  • Smaller reporting company

CNS Pharmaceuticals, Inc.

Sign in to watch
Ticker
CNSP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
822318545
Phone
+1 800-946-9185
Business address
2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Chief Financial Officer bought 27,000 shares at $1.27 ($34,177)
  7. 4 Open-market buy Chief Executive Officer bought 2,750 shares at $1.80 ($4,945)
  8. 4/A Derivatives Options or other derivatives
  9. 4 Planned sale 10% owner sold 94,298 shares at an average $1.41 ($133,114)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Exercise or conversion Chief Executive Officer acquired 1,250 shares (option exercise)
  13. 4 Exercise or conversion Chief Financial Officer acquired 521 shares (option exercise)
  14. 4 Open-market buy Director bought 2,500 shares at $1.70 ($4,250)
  15. 4 Open-market buy Chief Financial Officer bought 3,100 shares at $3.20 ($9,920)
  16. 4 Open-market buy Director bought 7,173 shares at $0.74 ($5,308)
  17. 4 Open-market buy Chief Executive Officer bought 15,000 shares at $0.69 ($10,409)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 5 · 90 filings